An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bradley Corr, MD
University of Colorado, Denver
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Hospital
Aurora, Colorado, United States
Bradley Corr, MDRecruiting - Northwestern Memorial Hospital
Chicago, Illinois, United States
Emma Barber, MDRecruiting - University of Pennsylvania Health System, Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
Stefan Gysler, MDRecruiting - Upmc Magee-Women'S Hospital
Pittsburgh, Pennsylvania, United States
Lisa Barroilhet, MDRecruiting - University of Wisconsin - Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Lisa Barroilhet, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Oct 2023
- Primary completion
- 31 Jan 2029
- Completion
- 31 Jan 2031
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 53
- Registry id
- NCT05887609
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.